olmesartan has been researched along with c-peptide in 1 studies
Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (c-peptide) | Trials (c-peptide) | Recent Studies (post-2010) (c-peptide) |
---|---|---|---|---|---|
841 | 185 | 554 | 9,053 | 1,632 | 2,445 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hanayama, Y; Kaihara, M; Makino, H; Nakamura, Y; Norii, H; Sugimoto, T; Uchida, HA | 1 |
1 other study(ies) available for olmesartan and c-peptide
Article | Year |
---|---|
Olmesartan and temocapril prevented the development of hyperglycemia and the deterioration of pancreatic islet morphology in Otsuka-Long-Evans-Tokushima Fatty rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; C-Peptide; Fructosamine; Hyperglycemia; Imidazoles; Insulin; Insulin-Secreting Cells; Male; Rats; Rats, Inbred OLETF; Receptor, Angiotensin, Type 1; Tetrazoles; Thiazepines | 2009 |